Utilization patterns of disease-modifying antirheumatic drugs in elderly rheumatoid arthritis patients

Xue Mei Jin, Joongyub Lee, Nam Kyong Choi, Jong Mi Seong, Ju Young Shin, Ye Jee Kim, Mi Sook Kim, Bo Ram Yang, Byung Joo Park

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

This study was conducted to investigate disease-modifying antirheumatic drug (DMARD) utilization in Korean elderly patients with rheumatoid arthritis (RA). We used data from January 1, 2005 to June 30, 2006 from the Health Insurance Review and Assessment Service claims database. The study subjects were defined as patients aged 65 yr or older with at least two claims with a diagnosis of RA. DMARD use was compared by the patients' age-group, gender, medical service, and geographic divisions. The patterns of DMARD use in mono- and combination therapy were calculated. RA medication use was calculated by the number of defined daily doses (DDD)/1,000 patients/day. A total of 166,388 patients were identified during the study period. DMARD use in RA patients was 12.0%. The proportion of DMARD use was higher in the younger elderly, females, and patients treated in big cities. Hydroxychloroquine was the most commonly used DMARD in monotherapy, and most of the combination therapies prescribed it with methotrexate. DMARD use in elderly RA patients was noticeably low, although drug prescriptions showed an increasing trend during the study period, clinicians may need to pay more attention to elderly RA patients.

Original languageEnglish
Pages (from-to)210-216
Number of pages7
JournalJournal of Korean Medical Science
Volume29
Issue number2
DOIs
StatePublished - 2014

Keywords

  • Antirheumatic agents
  • Arthritis, rheumatoid
  • Database
  • Utilization

Fingerprint

Dive into the research topics of 'Utilization patterns of disease-modifying antirheumatic drugs in elderly rheumatoid arthritis patients'. Together they form a unique fingerprint.

Cite this